Economic evaluation of a combined DTPa, hepatitis B, polio, Hib vaccine: Potential impact of the introduction of Infanrix-Hexa in the French childhood immunisation schedule

European Journal of Health Economics

Volumn 5, Issue 2, 2004, Pages 143-149

  Fagnani, Francis ^a   Le Fur, Camille ^b   Durand, Isabelle ^b   Gibergy, Michel ^b  

^a CEMKA EVAL   (France)

^b GSK

Author keywords

Combination vaccine; Cost; France; Infant; Pricing

Indexed keywords

DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; ENGERIX B10; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; POLIOMYELITIS VACCINE; RECOMBINANT HEPATITIS B VACCINE; UNCLASSIFIED DRUG;

ARTICLE; COST MINIMIZATION ANALYSIS; DIPHTHERIA; DRUG COST; ECONOMIC EVALUATION; FRANCE; HAEMOPHILUS INFLUENZAE TYPE B; HEPATITIS B; HUMAN; IMMUNIZATION; INFECTION PREVENTION; INFECTION RISK; PERTUSSIS; POLIOMYELITIS; PRIORITY JOURNAL; REIMBURSEMENT; TETANUS;

CHILD; COSTS AND COST ANALYSIS; DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FRANCE; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; POLIOVIRUS VACCINES; POLYSACCHARIDES, BACTERIAL; VACCINES, COMBINED;

EID: 3042579621     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Calendrier Vaccinal (2003) Avis du Conseil Supérieur d'Hygiène Publique de France. BEH 6:33-37
2. Bonanni P, Jilg W (2002) Influence of combined vaccines on infant immunisation coverage - recent data from Italy, Germany and Belgium. Viral Hepatitis 10:10-13
3. Eskola J, Ward J, Dagan R, Goldblatt D, Zepp F, Siegrist CA (1999) Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis. Lancet 354:2063-2068
4. Conseil Supérieur d'Hygiène Publique de France (2002) Avis du Conseil Supérieur d'Hygiène Publique de France concernant la vaccination contre l'hépatite B virale. Séance du 4 mars. Bulletin Officiel Ministère Emploi Solidarité 13:377-378
5. Comité Technique des Vaccinations (1998) Avis du Comité Technique des Vaccinations et de la Section des Maladies Transmissibles du Conseil Supérieur d'Hygiène Publique de France concernant la vaccination contre l'hépatite B. Séance du 17 et du 23 juin. BEH 44-98
6. Jacobson SH, Sewell EC (2002) Using Monte-Carlo simulation to determine combination vaccines price distribution for childhood disease. Health Care Manage Sci 5:135-45
7. CDC (1999) Combination vaccines for childhood immunization. Morb Mortal Wkly Rep 48:1-15
8. Dietz VJ, Stevenson J, Zell ER, Cochi S, Hadler S, Eddins D (1994) Potential impact on vaccination coverage levels by administering vaccines simultaneously and reducing dropout rates. Arch Pediatr Adolesc Med 148:943-949
9. Kuppermann M, Nease RF Jr, Ackerson LM, Black SB, Shinefield HR, Lieu TA (2000) Parents' preferences for outcomes associated with childhood vaccinations. Pediat Infect Dis J 19:129-133
10. Meyerboff As, Weniger BG, Jacobs RJ (2001) Economic value to parents of reducing pain and emotional distress of childhood vaccine injections. Pediat Infect Dis J 20 [Suppl 11]:S57-62
11. Dartigues JF (2002) Rapport Mission d'expertise sur la politique de vaccination contre l'hépatite B en France. Ministère de la Santé, Paris
12. Bonanni P, Bergamini M (2002) Factors influencing vaccine uptake in Italy. Vaccine 20:S8-S12
13. Swennen B, Van Damme P, Vellinga A, Coppieters Y, Depooter AM (2002) Analysis of factors influencing vaccine uptake: perspectives from Belgium. Vaccine 20:S5-S7
14. Madlon-Kay D, Harper PG (1994) Too many shots? Parent, nurse and physician attitudes toward multiple simultaneous childhood vaccinations. Arch Fam Med 3:610-613
15. Lieu, TA, Black SB, Ray GT (2000) The hidden costs of infant vaccination. Vaccine 19:33-41